No Data
No Data
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok Program and Pathway to Approval
Citius Pharmaceuticals Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Citius Pharmaceuticals To Carry Out 1-for-25 Reverse Stock Split On November 26th, 2024
D. Boral Capital Downgrades Citius Pharmaceuticals(CTXR.US) to Hold Rating
Citius Pharmaceuticals Cut to Hold From Buy by D. Boral Capital
No Data
No Data
温水煮青蛙 : Will it rise tomorrow?
John2000 温水煮青蛙 : Must fall
温水煮青蛙 John2000 : I sold it then.
Teddy123 OP John2000 : I'm holding on still